MX347135B - Composición farmacéutica de sabor enmascarado para administración oral, y proceso para la preparación de la misma. - Google Patents

Composición farmacéutica de sabor enmascarado para administración oral, y proceso para la preparación de la misma.

Info

Publication number
MX347135B
MX347135B MX2014004811A MX2014004811A MX347135B MX 347135 B MX347135 B MX 347135B MX 2014004811 A MX2014004811 A MX 2014004811A MX 2014004811 A MX2014004811 A MX 2014004811A MX 347135 B MX347135 B MX 347135B
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
active ingredient
taste
oral
oral administration
Prior art date
Application number
MX2014004811A
Other languages
English (en)
Other versions
MX2014004811A (es
Inventor
Chul Chang Hee
Han Park Sang
Ki Kang Bok
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Publication of MX2014004811A publication Critical patent/MX2014004811A/es
Publication of MX347135B publication Critical patent/MX347135B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica para administración oral, en la que el sabor del ingrediente farmacéuticamente activo está enmascarado, preparada por granulación húmeda de una mezcla de un ingrediente farmacéuticamente activo, al menos un compuesto seleccionado del grupo constituido por aluminometasilicato de magnesio y silicato de calcio, y un vehículo farmacológicamente aceptable, y un método de preparación de la composición farmacéutica. La composición farmacéutica oral se puede preparar sin utilizar un sistema de fabricación o aditivo costoso especial, tiene un efecto de enmascaramiento del sabor desagradable de los ingredientes activos, y exhibe un comportamiento apropiado de disolución del fármaco en el cuerpo para manifestación del efecto farmacéutico. Asimismo, la composición farmacéutica oral es compatible a la vez con un ingrediente activo soluble en agua y un ingrediente activo poco soluble en agua, con aplicabilidad industrial alta debido a procesos de fabricación simples y altas eficiencia económica y productividad. La composición farmacéutica oral puede formularse en cualquiera de una diversidad de formas de dosificación sólidas con características farmacéuticas mejoradas.
MX2014004811A 2011-10-21 2012-10-11 Composición farmacéutica de sabor enmascarado para administración oral, y proceso para la preparación de la misma. MX347135B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110108119 2011-10-21
PCT/KR2012/008230 WO2013058496A1 (en) 2011-10-21 2012-10-11 Taste-masked pharmaceutical composition for oral administration and a process for the preparation thereof

Publications (2)

Publication Number Publication Date
MX2014004811A MX2014004811A (es) 2014-08-27
MX347135B true MX347135B (es) 2017-04-12

Family

ID=48141097

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004811A MX347135B (es) 2011-10-21 2012-10-11 Composición farmacéutica de sabor enmascarado para administración oral, y proceso para la preparación de la misma.

Country Status (5)

Country Link
JP (1) JP5859664B2 (es)
BR (1) BR112014009438A2 (es)
MX (1) MX347135B (es)
RU (1) RU2583935C2 (es)
WO (1) WO2013058496A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
JP7162959B2 (ja) * 2017-06-30 2022-10-31 大鵬薬品工業株式会社 固形製剤
BR112020014376A2 (pt) 2018-01-16 2020-12-01 Appili Therapeutics Inc. composição farmacêutica oral, e, método para tratar uma infecção em um paciente.
CN108392639A (zh) * 2018-04-13 2018-08-14 江苏亚邦爱普森药业有限公司 一种含有枸橼酸西地那非的药物组合物及其制备方法
WO2020150460A1 (en) * 2019-01-18 2020-07-23 Milne Iii Donald A Micronized aspirin formulation
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan
WO2021207336A1 (en) * 2020-04-08 2021-10-14 Verté Therapeutics, Llc Oral formulations for sustained release and gastrointestinal retention
WO2022106923A1 (en) 2020-11-18 2022-05-27 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3731904B2 (ja) * 1993-10-29 2006-01-05 エーザイ株式会社 粒状固形製剤
JP2004010611A (ja) * 2002-06-06 2004-01-15 Nisshin Yakuhin Kogyo Kk マスキング組成物
WO2004028268A1 (en) * 2002-09-24 2004-04-08 Gumlink A/S Chewing gum comprising at least two different biodegradable polymers
RU2355184C2 (ru) * 2004-07-06 2009-05-20 Гумлинк А/С Таблетка прессованной жевательной резинки и способ ее получения
JP2009263298A (ja) * 2008-04-28 2009-11-12 Ss Pharmaceut Co Ltd 不快な味を隠ぺいした経口組成物
KR20100031282A (ko) * 2008-09-12 2010-03-22 보령제약 주식회사 메만틴염산염 구강 속붕해정

Also Published As

Publication number Publication date
RU2583935C2 (ru) 2016-05-10
WO2013058496A1 (en) 2013-04-25
RU2014115287A (ru) 2015-11-27
BR112014009438A2 (pt) 2017-04-11
JP5859664B2 (ja) 2016-02-10
MX2014004811A (es) 2014-08-27
JP2014532081A (ja) 2014-12-04

Similar Documents

Publication Publication Date Title
MX347135B (es) Composición farmacéutica de sabor enmascarado para administración oral, y proceso para la preparación de la misma.
ZA201608614B (en) Solid oral pharmaceutical compositions for isoxazoline compounds
PH12018500147A1 (en) Benzodiazepine derivatives as rsv inhibitors
WO2011076749A3 (en) Solid pharmaceutical dosage form of ticagrelor
HRP20160605T1 (hr) Tetraciklički spoj
UA106634C2 (uk) Тверда фармацевтична дозована форма
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
PH12015501015B1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2005107721A3 (en) Pharmaceutical dosage form comprising pellets as well as its manufacturing process
WO2010097243A3 (en) Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts
PH12014501408A1 (en) Immediate release multi unit pellet system
IN2013MU02206A (es)
RU2014129508A (ru) Новая комбинация
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
MD4563C1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen
PH12014502836B1 (en) Medicament form for release of active ingredients
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
UA108277C2 (ru) Комплексный препарат, содержащий лерканидипина гидрохлорид и валсартан, и способ его получения
EA201390911A1 (ru) Фармацевтическая композиция, содержащая растительное действующее вещество
RU2012136190A (ru) Фармацевтический состав для профилактики или лечения артрозоартрита, содержащий ребамипид в качестве активного ингредиента
MX2017013643A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.
MX2011012045A (es) Composiciones con liberacion rapida de farmaco.
MX2017013634A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.

Legal Events

Date Code Title Description
FG Grant or registration